SPARC’s Q1 net loss widens to Rs 78.84 crore

07 Aug 2017 Evaluate

Sun Pharma Advanced Research Company (SPARC) has reported results for first quarter ended June 30, 2017.

The company has reported a net loss of Rs 78.84 crore for the quarter under review as against a net loss of Rs 36.14 crore for the same quarter in the previous year. However, total income of the company increased marginally by 0.49% at Rs 24.62 crore for Q1FY18 as compared Rs 24.50 crore for the corresponding quarter previous year.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

124.65 -4.70 (-3.63%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 542.55
Indegene 474.00
CMS Info Systems 319.15
Sagility 51.76
Smartworks Coworking 438.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×